Does the CNNM2 rs11191548 variant lower circulating magnesium?

Large-scale genomic studies and physiological research have established a clear link between the CNNM2 gene and the regulation of systemic magnesium. Specifically, the rs11191548 variant is recognized as a key genetic determinant of how the body maintains its magnesium balance.

Genetic and clinical evidence

Research from major genome-wide association studies (GWAS), including the CHARGE consortium, has consistently identified the CNNM2 locus as one of the most significant regions influencing serum magnesium concentrations.

• Association: The rs11191548 variant serves as a lead single nucleotide polymorphism (SNP) for this effect. Specifically, individuals carrying the minor allele of this variant exhibit significantly lower circulating magnesium levels compared to those with the common variant.
• Clinical relevance: While the effect size of a single SNP like rs11191548 is typically modest within the general population, its influence is reproducible across different cohorts, confirming its role in the complex trait of magnesium homeostasis. In more severe cases, loss-of-function mutations in the CNNM2 gene are known to cause dominant familial hypomagnesemia, characterized by severe magnesium wasting.

Mechanistic explanations

The CNNM2 gene encodes Cyclin M2, a protein essential for the transport of magnesium across cell membranes, particularly within the kidneys.

• Renal reabsorption: CNNM2 is highly expressed in the basolateral membrane of the distal convoluted tubule (DCT) in the kidney. This is the site where the final "fine-tuning" of magnesium reabsorption occurs before urine is excreted.
• Transport dysfunction: The physiological role of CNNM2 is to facilitate the efflux of magnesium from the DCT cells back into the bloodstream. The rs11191548 variant, along with others in the cystathionine-β-synthase (CBS) domains of the protein, appears to impair this transport efficiency.
• Magnesium wasting: When CNNM2 function is reduced, the kidney cannot effectively move magnesium from the filtered tubule fluid back into the blood. This results in increased urinary magnesium loss and a corresponding decrease in serum concentrations.

Bottom line

The claim that CNNM2 rs11191548 variants are associated with lower circulating magnesium is strongly supported by scientific evidence. This association is driven by impaired renal magnesium reabsorption, where genetic variations reduce the efficiency of magnesium transport from the kidneys back into systemic circulation.